Arc 10Sanqing’s Expanding Reach
Sanqing Pharmaceutical’s fast-acting locust pesticide brought the company international attention, while its medicines helped patients and its gene-editing work advanced in healthcare and agriculture. The arc ended with high-yield Super Soybeans and other improved crops entering wider trials.
- Chinese agricultural officials tested Sanqing’s low-toxicity pesticide, and Xia Lizhi used it to kill locusts in Pakistan within minutes.
- Ethiopian officials chose Three Purities’ insecticide after seeing its success, and countries across the affected regions placed large orders through Syngenta.
- Sun Chengren and Gu Xian negotiated medicine sales in Africa, while Salman brought Thalassemia patients to China and Sanqing began developing a tailored Gene Drug.
- Wang De and Three Purities formed a partnership to develop gene-edited crops, producing soybean samples that Syngenta planted for trials.
- Sanqing’s experimental cardiovascular drugs helped Song Zhi Xing recover from paralysis, and his reunion with wartime comrades followed.
- Sanqing developed a Thalassemia Gene Drug that restored Salman’s health, then launched a charity foundation to fund treatment trials for other patients.
- Brother Jiazhen exposed weaknesses in other fundraising platforms and showed that Sanqing’s Longtu APP checked applicants’ eligibility before approving aid.
- Wang De’s team measured Super Soybean yields above 1,000 jin per mu for one variety and prepared wider trials of the soybeans and other improved crops.